Watchlist for April 28, 2008

The indices remain close to their February highs resistance levels and I wouldn't be surprised at all if they don't move much until Wednesday's Fed decision.

On Today's Calendar:

nothing.

More Calendars: U.S. Earnings | Conf. Calls | Surprises | IPO | Economic

Potential swing trades:

See one of the recent 'Chart Reading' posts for some potential swing candidates. Also be sure to check my typical swing trade entry & exit rules.

Potential day trades:

(From Briefing.com)

Gapping Down

In reaction to disappointing earnings/guidance: SCMR -14.2%, RDWR -10.7%, SSW -3.7%, SNP -3.5%, LFC -3.4%, SILC -3.2%, IBN -2.5%, PNCL -2.1%, RSH -1.4%... Other news: GMST -20.4% (no specific catalyst; note shareholders vote on MVSN merger tomorrow), MEDX -12.0% (co and BMY announce that the cos will delay the Biologics License Application submission for ipilimumab), CAL -5.1% (rejects merger overtures - WSJ), UBS -2.4% (still checking), LOGI -1.9% (still checking)... Analyst downgrades: UAUA -6.6% (downgraded to Neutral at Credit Suisse), GT -6.6% (downgraded to Neutral at JPMorgan), SHPGY -3.2% (downgraded to Underperform at Credit Suisse), SNCR -2.5% (downgraded to Accumulate at ThinkPanmure), CHE -2.0% (downgraded to Neutral at JPMorgan), AIG -1.6% (downgraded to Neutral at Credit Suisse), POT -1.5% (Hearing removed from Buy List at tier 1 firm), BEBE -1.3% (downgraded to Hold at Brean Murray), ARO -1.2% (downgraded to Neutral at boutique firm), MMR -1.1% (downgraded to Hold at Jefferies), KSS -1.1% (downgraded to Neutral at Baird).

Gapping Up

In reaction to strong earnings/guidance: SOHU +13.5% (SINA +6.3%, NTES +4.4%, SNDA +4.0% trading higher in sympathy), BEAV +6.1%, EPD +5.0%, BBD +4.2%, CEO +2.9%, VZ +2.1%... M&A news: WWY +25.4% (Wrigley and Mars announce merger agreement for $80 per WWY share in cash)... Select mining/metals stocks showing strength with higher spot prices: LMC +2.9%, GOLD +2.6%, AEM +1.9%, MT +1.6% (plans surcharge for its steel customers - WSJ), AUY +1.6%, AAUK +1.0%... Other news: OSTE +13.3% (Osteotech's Plexur P receives FDA clearance as bone void filler and bone graft extender in spine), IMMR +10.2% (modestly rebounding after last week's 18% drop), F +8.5% (Tracinda announces it intends to make a cash tender offer for up to 20 mln shares stock at a price of $8.50 per share), HSY +5.6% (up in sympathy with WWY), ACGY +4.0% (still checking), AERG +3.9% (receives $4.5 mln U.S. Army contract for laser guided energy program), ABK +3.6% (modestly rebounding from last week's 40%+decline), VMED +2.9% (still checking), CMI +2.9% and DISCA +2.8% (Cramer makes positive comments on MadMoney)... Analyst upgrades: CS +2.6% (upgraded to Peer Perform at Bear Sterns and upgraded to Neutral at tier 1 firm), V +2.4% (initiated with Buy at UBS and initiated with Buy at tier 1 firm and initiated with Buy at SunTrust), NCC +2.2% (upgraded to Outperform from Market Perform at BMO Capital), MRVL +2.1% (upgraded to Outperform at Friedman Billings), MASI +1.8% (upgraded to Buy at Citigroup).